Gene therapy: Engineered ‘heart-healing virus’ trial starts

| | April 30, 2013
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

The following is an excerpt.

Patients in the UK have been enrolled into a trial to see if an engineered virus can be used to heal their damaged and struggling hearts.

The trial will use a virus to introduce genetic material into heart muscle to reverse the organ’s decline.

The British Heart Foundation said the idea had “great potential” but needed to be proven in clinical trials.

Read the full article here: Gene therapy: ‘Heart-healing virus’ trial starts

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend